AXT Inc. Hits All-Time High at $52 on Upbeat Chip Guidance, but 113x Earnings Is a Steep Price
NEW YORK, April 3 —
AXT Inc. (AXTI) surged to $52.84 after management signaled Q1 results will come in strong.
- Stock at $52.84 on positive pre-earnings commentary, down from $70.88 all-time high in March
- Forward P/E of 113.2x on just $88mn in trailing twelve-month revenue
- Formal Q1 2026 earnings report upcoming; specific revenue and EPS figures still to be confirmed
What Actually Happened
AXT makes compound semiconductor substrates — the wafers underneath chips used in 5G infrastructure, data centers, and electric vehicles. These aren't the silicon wafers Intel uses. They're indium phosphide and gallium arsenide, specialty materials where AXT is one of a handful of global suppliers.
Management got ahead of the formal earnings release with upbeat Q1 commentary. That's unusual for a company this size. Small-cap semiconductor names typically don't preview quarters unless the numbers are genuinely better than the street expects. The stock ripped to levels it has never traded at before.
Compound semiconductors are in a cyclical recovery after a brutal 2023-2024 downturn that crushed substrate demand. AXT's $88mn TTM revenue is still well below its prior peak. If the cycle is turning, the order book has room to run.
The Catch
At 113x forward earnings, AXT is priced like a high-growth SaaS company, not a substrate manufacturer running $88mn in revenue. The math requires earnings to roughly triple just to bring the multiple down to semiconductor-industry norms around 25-35x. That's a lot of wafers.
There's also a concentration problem. AXT sells to a small number of compound semiconductor device makers. One large customer pausing orders can swing an entire quarter. The company's manufacturing is based in China, which adds trade-policy risk that has only grown louder in 2026.
Bottom Line
The signal from management is real. Companies don't preview good quarters for fun. But this stock now needs the actual Q1 numbers to justify a valuation that has already priced in the recovery and then some. If revenue growth doesn't accelerate past $88mn annualized, the 113x multiple becomes very hard to defend.
This is a momentum trade until proven otherwise. The number to watch: Q1 revenue growth quarter over quarter. Anything below double-digit sequential acceleration, and the all-time high becomes a ceiling, not a floor.
For a full breakdown of AXT Inc.'s fundamentals, generate a free report at Basis Report for AXTI.
Basis Report does not hold positions in securities discussed. This is not investment advice.
Sources & filings